ecancermedicalscience

Case Report

Surgical treatment in oligometastatic breast cancer

20 May 2019
Catalina Vargas, Cristóbal Maiz, María Elena Navarro, David Oddó, Cesar Sánchez, Marisa Bustos, Mauricio Camus

Metastatic breast cancer (MBC) management is based on systemic treatment (ST), while the local therapy role remains controversial. We present the case of a 36-year-old woman with a diagnosis of hormone receptor-positive and human epidermal growth factor receptor type 2-positive breast cancer and isolated sternal metastasis, who received neoadjuvant ST with complete remission and later primary tumour surgery. Oligometastatic patients are a subgroup of MBC that can benefit from aggressive local therapies, even with curative intent.

Article metrics: 531 views
378
153

Related Articles

Aline F Fares, Daniel V Araujo, Vinicius Calsavara, Augusto Obuti Saito, Maria Nirvana Formiga, Aldo A Dettino, Stenio Zequi, Walter H da Costa, Isabela W Cunha
Luiz Fernando Quintanilha, Laumar Neves Souza, Daniel Sanches, Kiyoshi Ferreira Fukutani
Gustavo Duarte Ramos Matos, Veridiana Pires de Camargo, Rodrigo Ramella Munhoz, Gilberto de Castro Jr